An in vitro study of the use of chelating agents in cleaning nickel-contaminated human skin: An alternative approach to preventing nickel allergic contact dermatitis

Contact Dermatitis

Volumn 39, Issue 4, 1998, Pages 171-181

  Healy, J ^a,c   Johnson, S ^a   Little, M C ^b   Macneil, S ^b  

^a HEALTH AND SAFETY LABORATORY   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

^c Magdalen House   (United Kingdom)

Author keywords

Complex; Cytotoxicity; Ligand; Nickel; Removal; Skin; Soap

Indexed keywords

CHELATING AGENT; CLIOQUINOL; DIETHYLDITHIOCARBAMIC ACID; DODECYL SULFATE SODIUM; EDETIC ACID; HISTIDINE; LIGAND; NICKEL; SOAP; SODIUM CHLORIDE;

ARTICLE; CLEANING; COMPARATIVE STUDY; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; NICKEL HYPERSENSITIVITY; PH; SOLUTION AND SOLUBILITY;

ADHESIONS; BUFFERS; CELL LINE; CELL SURVIVAL; CHELATING AGENTS; CHEMISTRY, PHYSICAL; CLIOQUINOL; DERMATITIS, ALLERGIC CONTACT; DITIOCARB; DOSE-RESPONSE RELATIONSHIP, DRUG; EDETIC ACID; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; NICKEL; OCTANOLS; POLYSTYRENES; QUINOLINES; SKIN; SKIN ABSORPTION; SOAPS; SODIUM CHLORIDE; SOLUBILITY; SURFACE PROPERTIES; TIME FACTORS; WATER;

EID: 0031752255     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1998.tb05889.x     Document Type: Article

References (29)

1. Rostenberg Jr A, Perkins A J. Nickel and cobalt dermatitis. J Allergy 1951: 22: 466-474.
2. Gawkrodger D J, Healy J, Howe A M. The prevention of nickel contact dermatitis. A review of the use of binding agents and barrier creams. Contact Dermatitis 1995: 32: 257-265.
3. Lee M H, Pankratz H S, Wang S et al. Purification and characterisation of Klebsiella aerogenes UreE protein: a nickel-binding protein that functions in unrease metallocenter assembly. Protein Sci 1993: 2: 1042-1052.
4. Friedrich B. Schwartz E. Molecular biology of hydrogen utilization in aerobic chemolithotrophs. Ann Rev Microbiol 1995: 47: 351-383.
5. Halbach S. The octanol/water distribution of mercury compounds. Arch Toxicol 1985: 57: 139-141.
6. Little M C, Gawkrodger D J, MacNeil S. Chromium-and nickel-induced cytotoxicity in normal and transformed human keratinocytes: an investigation of pharmacological approaches to the prevention of Cr (VI)-induced cytotoxicity. Br J Dematol 1996: 134: 199-207.
7. Weast R C, Lide D R, Astle M J, Beyer W H (eds): Handbook of chemistry and physics. Boca Raton, Florida: CRC Press, 1990: 70: D-145.
8. Stability constant database (Release 2). IUPAC and Academic Software 1995, Otley, UK.
9. Tanaka H, Tamura Z. Determination of the partition coefficient and acid dissociation constants of iodochlorhydroxyquin by an improved partition method. J Pharm Sci 1984: 73: 1647-1649.
10. Carini F F, Martell A E. The effect of potassium chloride on the equilibrium between ethylenediaminetetraacetate and calcium ions. J Am Chem Soc 1952: 74: 5745-5748.
11. Kortum G, Vogel W, Andrussow K. Dissociation constants of organic acids in aqueous solution. London: Butterworths, 1961.
12. Purcell W P, Bass G E, Clayton J M. Strategy of drug design: a guide to biological activity. New York: John Wiley and Sons, Inc, 1973: 126-143.
13. Comer J. The acid test. Chem Br 1994: 30: 983-986.
14. Fullerton A, Anderson J R, Hoelgaard A. Permeation of nickel through human skin in vitro: effect of vehicles. Br J Dermatol 1988: 118: 509-516.
15. Fullerton A, Hoelgaard A. Binding of nickel to human epidermis in vitro. Br J Dermatol 1988: 119: 675-682.
16. Hogan D J, Dannaker C J, Lal S, Maibach H I. An international survey on the prognosis of occupational contact dermatitis of the hands. Denn Beruf Umwelt 1990: 35: 143-147.
17. Ezedeen F W, Stohs S I, Kilzer K L et al. Percutaneous absorption and disposition of iodochlorohydroxyquin in dogs. J Pharm Sci 1984: 73: 1369-1372.
18. Kauffman R E, Banner Jr W, Blumer J L et al. Clioquinol (Iodochlorohydroxyquin, Vioform) and lodoquinol (Diiodohydroxyquin): blindness and neuropathy. Pediatrics 1990: 86: 797-798.
19. Fischer T, Hatvig P. Skin absorption of 8-hydroxyquinolines. Lancet 1977: i: 603.
20. Stohs S J, Ezzedeen F W, Anderson A K et al. Percutaneous absorption of iodochlorhydroxyquin in humans. J Invest Dermatol 1984: 82: 192-198.
21. Martindale W. The Extra Pharmacopoeia, Reynolds J E F (ed), 30th edition. London: Pharmaceutical Press, 1993: 511.
22. Heindorff K, Aurich O, Michaelis A, Rieger R. Genetic toxicology of ethylenediaminetetraacetic acid (EDTA). Mutation Res 1983: 115: 149-173.
23. Christensen J D. Dilsulfiram treatment of three patients with nickel dermatitis. Contact Dermatitis 1982: 8: 105-108.
24. Kaaber K, Menné T, Tjell J C, Veien V. Antabuse treatment of nickel dermatitis. Chelation: a new principle in the treatment of nickel dermatitis. Contact Dermatitis 1979: 5: 221-228.
25. Hopfer S M, Linden J V, Rezuke W H et al. Increased nickel concentrations in body fluids of patients with chronic alcoholism during disulfiram therapy. Res Comm Chem Path Pharm 1987, 55: 101-109.
26. Scheuplein R J. Mechanism of percutaneous adsorption. I Routes of penetration and the influence of solubility. J Invest Derm 1965: 45: 334-346.
27. Sharata H H, Burnette R R. Effect of dipolar aprotic permeability enhancers on the basal stratum corneum. J Pharm Sci 1988: 77: 27-32.
28. Hostynek J J, Hinz R S, Lorence C R et al. Metals and the skin. Crit Rev Toxicol 1993: 23: 171-235.
29. Samitz M H, Katz S A. Nickel-epidermal interactions: diffusion and binding. Environ Res 1976: 11: 34-39.